ロード中...

The role of B cells in multiple sclerosis: current and future therapies

While it was long held that T cells were the primary mediators of multiple sclerosis (MS) pathogenesis, the beneficial effects observed in response to treatment with Rituximab, a monoclonal antibody (mAb) targeting CD20, shed light on a key contributor to MS that had been previously underappreciated...

詳細記述

保存先:
書誌詳細
出版年:Cell Immunol
主要な著者: Negron, Austin, Robinson, Rachel R., Stuve, Olaf, Forsthuber, Thomas G.
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6540809/
https://ncbi.nlm.nih.gov/pubmed/31130183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2018.10.006
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!